PIGR Antikörper (C-Term)
Kurzübersicht für PIGR Antikörper (C-Term) (ABIN453783)
Target
Alle PIGR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- This antibody reacts to PIGR.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide selected from the C-terminal region of human PIGR
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PIGR (Polymeric Immunoglobulin Receptor (PIGR))
-
Andere Bezeichnung
- PIGR
-
Hintergrund
- PIGR binds polymeric IgA and IgM at the basolateral surface of epithelial cells. The complex is then transported across the cell to be secreted at the apical surface. During this process a cleavage occurs that separates the extracellular (known as the secretory component) from the transmembrane segment.Synonyms: Hepatocellular carcinoma-associated protein TB6, PIG-R, Poly-Ig receptor, Polymeric immunoglobulin receptor
-
Gen-ID
- 5284
-
NCBI Accession
- NP_002635
-
UniProt
- P01833
Target
-